Sarcoma  >>  peripheral blood stem cell transplantation  >>  Phase 1
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
peripheral blood stem cell transplantation / National Cancer Institute
NCT00003081: Combination Chemotherapy, Peripheral Stem Cell Transplantation, and Radiation Therapy in Treating Patients With Ewing's Sarcoma, Peripheral Primitive Neuroectodermal Tumor, or Rhabdomyosarcoma

Completed
1
16
US
filgrastim, busulfan, melphalan, thiotepa, peripheral blood stem cell transplantation, radiation therapy
Fred Hutchinson Cancer Center, National Cancer Institute (NCI)
Sarcoma
01/02
01/02
NCT00003141: Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Infants With Malignant Brain or Spinal Cord Tumors

Completed
1
94
US, Canada, RoW
filgrastim, GRANULOCYTE COLONY-STIMULATING FACTOR, r-metHuG-CSF, G-CSF, carboplatin, Paraplatin, CBDCA, NSC #241240, cisplatin, Cis-diamminedichloroplatinum II, Platinol-AQ, NSC #119875, cyclophosphamide, CTX, Cytoxan, NSC #026271, etoposide, VP-16, VePesid, Etopophos, NSC #141540, thiotepa, Tespa, Tspa, NSC #639, vincristine sulfate, VCR, Oncovin, NSC #067574, conventional surgery, peripheral blood stem cell transplantation
Children's Oncology Group, National Cancer Institute (NCI)
Brain Tumors, Central Nervous System Tumors, Neuroblastoma, Sarcoma
12/07
10/11

Download Options